10-K: Genworth Financial 2025 Annual Report: Strategic Shift & Growth

Genworth Financial's 2025 Annual Report highlights a strategic pivot to CareScout for growth, continued capital returns from Enact, and ongoing management of its Closed Block legacy insurance products.

Summary

• Genworth Financial has reorganized its reportable segments into 'Enact' (private mortgage insurance) and 'Closed Block' (legacy long-term care, life, and annuity products), effective Q4 2025.
• The company is driving future growth through its CareScout business, which includes CareScout Services (fee-based aging care services) and CareScout Insurance (new long-term care insurance products).
• In October 2025, Genworth acquired Seniorly, a senior living platform, to expand CareScout Services' network and accelerate direct-to-consumer market entry.
• CareScout Insurance launched a new individual long-term care insurance product, Care Assurance, in October 2025, now live in 40 states, designed with conservative pricing.
• Enact Holdings provided $407 million in capital returns to Genworth Holdings in 2025, comprising $309 million from share repurchases and $98 million from quarterly dividends.
• Genworth Financial repurchased $245 million of its common stock in 2025 and authorized a new $350 million share repurchase program in September 2025.
• The Closed Block segment continues to implement its multi-year in-force rate action plan for long-term care insurance, achieving an estimated cumulative economic benefit of $34.5 billion (NPV) from 2012-2025.
• Net income available to Genworth Financial, Inc.'s common stockholders was $223 million in 2025, down from $299 million in 2024.
• Adjusted operating income available to Genworth Financial, Inc.'s common stockholders decreased to $144 million in 2025 from $273 million in 2024.
• Enact segment's adjusted operating income decreased by 5% to $558 million in 2025, primarily due to lower reserve releases and higher new delinquencies.
• Closed Block segment's adjusted operating loss increased by 48% to $317 million in 2025, mainly due to unfavorable long-term care insurance assumption updates.
• Genworth Holdings had $234 million of unrestricted cash and cash equivalents as of December 31, 2025.
• The company corrected the measurement of its reinsurance recoverable for traditional life insurance products, reducing equity by $50 million after-tax as of December 31, 2022, and increasing net income by $11 million in Q4 2025.
• Total assets increased by $1,262 million to $88,083 million, and total liabilities increased by $876 million to $78,316 million as of December 31, 2025.
• Total equity increased by $386 million to $9,767 million as of December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with a slightly negative sentiment due to the significant decline in net income and adjusted operating income, primarily driven by challenges in the Closed Block segment. While strategic growth initiatives in CareScout and strong capital returns from Enact are positive, the immediate financial results reflect headwinds and ongoing litigation risks.

Positives

• Enact Holdings provided significant capital returns of $407 million to Genworth Holdings in 2025, demonstrating its value generation.
• Genworth Financial authorized a new $350 million share repurchase program in September 2025, signaling continued commitment to shareholder returns.
• CareScout Services expanded its network to approximately 790 home care providers with over 1,000 locations nationwide, indicating strong operational growth.
• The acquisition of Seniorly is expected to accelerate CareScout's expansion into the direct-to-consumer market and broaden its network to include assisted living communities.
• CareScout Insurance launched a new individual long-term care insurance product, Care Assurance, in 40 states with conservative pricing assumptions to mitigate future premium rate increases.
• The multi-year in-force rate action plan for long-term care insurance achieved an estimated cumulative economic benefit of $34.5 billion (NPV) from 2012-2025, making meaningful progress towards the $39.5 billion target.
• Enact's PMIERs sufficiency ratio was 162% ($1,919 million above requirements) as of December 31, 2025, indicating strong capital position.
• Enact Holdings entered into a new $435 million five-year unsecured revolving credit facility, enhancing its financial flexibility.
• Enact Holdings authorized a new $500 million share repurchase program in February 2026, with Genworth Holdings participating to maintain its ownership interest.
• The consolidated RBC ratio of legacy insurance subsidiaries was approximately 300% as of December 31, 2025, exceeding minimum required levels.
• A $24 million tax benefit was recognized in 2025 related to a release of a portion of the valuation allowance on certain deferred tax assets.
• A $21 million gain was recorded in Q2 2025 related to a third-party reinsurance recapture in long-term care insurance.
• The company's internal control over financial reporting was effective as of December 31, 2025.

Negatives

• Net income available to common stockholders decreased by 25% to $223 million in 2025 from $299 million in 2024.
• Adjusted operating income decreased by 47% to $144 million in 2025 from $273 million in 2024.
• Enact segment's adjusted operating income decreased by 5% in 2025, primarily due to lower reserve releases and higher new delinquencies.
• The Closed Block segment's adjusted operating loss increased by 48% to $317 million in 2025, mainly due to unfavorable cash flow assumption updates in long-term care insurance.
• Long-term care insurance products experienced an unfavorable pre-tax impact of $47 million from annual cash flow assumption updates in Q4 2025, driven by unfavorable benefit utilization and healthy life assumptions.
• Net insurance recoveries of $22 million in 2024 for long-term care insurance did not recur in 2025, contributing to the increased operating loss.
• Lower spread income in annuity products in 2025 was driven mostly by block runoff.
• Genworth Holdings' unrestricted cash and cash equivalents decreased to $234 million as of December 31, 2025, from $294 million in 2024, due to share repurchases, CareScout investments, and debt interest payments.
• The change in the discount rate used to measure future policy benefits and related reinsurance recoverables decreased total equity by $559 million in 2025.
• Treasury stock increased by $248 million in 2025 due to common stock repurchases, decreasing total equity.
• The company recorded a $6 million charge to net income in 2025 for life insurance products due to expected benefits exceeding expected gross premiums for certain cohorts.
• The delinquency rate for Enact's loan portfolio increased to 2.62% as of December 31, 2025, from 2.45% in 2024.
• The company is in litigation with one state that has refused to approve actuarially justified rate increases for certain long-term care products.
• The company is a defendant in multiple putative class action lawsuits related to the MOVEit Cybersecurity Incident, alleging negligence and breach of contract.
• The company is a defendant in a putative class action lawsuit (TVPX ARS, INC. v. GLAIC) alleging unlawful and excessive cost of insurance charges on life insurance policies.
• The company is a defendant in a putative class action lawsuit (Burkhart et al. v. Genworth Financial et al.) alleging fraudulent transfer and inadequate capital maintenance by GLIC.
• The company is a defendant in a putative class action lawsuit (Trauernicht et al v. Genworth Financial) alleging breach of fiduciary duties under ERISA related to retirement investment options.
• The company is a defendant in a putative class action lawsuit (Fox v. GLAIC) alleging wrongful termination of California life insurance policies.
• The company is a defendant in a putative class action lawsuit (Kaplan v. GLIC) alleging misrepresentation and failure to disclose information regarding pricing and rate increases for long-term care insurance policies.

Risks

• New lines of business or new products and services, such as those with CareScout, may not be successful or may subject the company to additional risks, including lower than anticipated customer demand, higher capital needs, and unforeseen events.
• The company may be required to increase reserves due to deviations from estimates and actuarial assumptions (e.g., morbidity, mortality, persistency, inflation), particularly for long-term care insurance, which could materially adversely affect financial condition.
• Inaccurate models used for pricing, reserves, and investment decisions could have a material adverse impact on business and financial results.
• Genworth Financial and Genworth Holdings depend on Enact Holdings' ability to pay dividends and make other payments, which could be impacted by market conditions, business performance, and regulatory requirements.
• Sources of capital have become more limited, and the company may need to seek additional capital on unfavorable terms, especially given risks associated with CareScout initiatives.
• Adverse rating agency actions could lead to loss of business, impact relationships with distributors, increase policy surrenders, require additional collateral, and increase borrowing costs.
• Defaults by counterparties to reinsurance arrangements or derivative instruments may expose the company to risks it sought to mitigate.
• Defaults or other events impacting the value of the fixed maturity securities portfolio may reduce income.
• Interest rates and changes in rates could materially adversely affect business and profitability, impacting investment valuations, hedging costs, and policyholder behavior (surrenders/withdrawals).
• A deterioration in economic conditions, a severe recession, or a decline in home prices could adversely affect Enact Holdings' loss experience and overall profitability.
• Changes in accounting and reporting standards could materially adversely affect business, financial condition, and results of operations.
• The inability to execute in-force management actions (including obtaining rate increases) on long-term care insurance products could have a material adverse impact on the Closed Block segment.
• Extensive regulation of insurance businesses and changes in regulation may reduce profitability and limit growth.
• Litigation and regulatory investigations are common and may result in financial losses and harm reputation.
• An adverse change in regulatory requirements on legacy insurance subsidiaries, including risk-based capital requirements, could have a material adverse impact.
• Changes to the charters or practices of the GSEs, including actions to decrease or discontinue mortgage insurance use, could adversely affect Enact's business.
• If Enact is unable to continue to meet PMIERs requirements, it may not be eligible to write new insurance on GSE-acquired loans, materially affecting its business.
• Enact Holdings' U.S. mortgage insurance subsidiaries are subject to minimum statutory capital requirements, which if not met, could result in restrictions on doing business.
• Changes in regulations affecting mortgage insurance markets (e.g., Dodd-Frank Act, Basel III Endgame) could reduce demand for mortgage insurance.
• Legacy insurance subsidiaries may not be able to continue to mitigate the impact of Regulations XXX or AXXX, incurring higher operating costs.
• Inability to retain, attract, and motivate qualified employees or senior management may adversely impact operations.
• Changes in Enact Holdings' business composition or undue concentration by customer/geographic region could cause significant loss or adverse performance.
• Ineffective disclosure controls and procedures or internal control over financial reporting could adversely impact business.
• Computer system failures, security compromises (cybersecurity incidents), issues from new technologies like AI, and problems with disaster recovery could expose confidential information, damage reputation, and impair business.
• Reliance on third-party vendors who may be unable or unwilling to meet obligations poses risks.
• Medical advances (genetic research, diagnostic imaging, AI) could materially adversely affect life and long-term care insurance and annuity products by impacting mortality, persistency, and underwriting risk.
• Other emerging risks, such as natural/man-made disasters, geopolitical tensions, public health emergencies, and climate change, could materially adversely affect business.

Future Outlook

Genworth Financial expects continued capital returns from Enact Holdings, with approximately $405 million anticipated in 2026 based on its 81% ownership. The company plans to continue expanding CareScout Services' offerings and customer base in 2026, with smaller capital investments anticipated for CareScout Insurance over the next few years. The multi-year in-force rate action plan for long-term care insurance aims to achieve an additional $5.0 billion (NPV) in economic benefit. The company anticipates lower intercompany cash tax payments to be retained by Genworth Holdings going forward. While quarterly variations in long-term care insurance results are expected, the company believes its investments in CareScout will drive sustainable future growth and maximize long-term shareholder value.

Management Comments

• "We continue to create shareholder value through Enact's growing market value and capital returns."
• "We believe capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction."
• "We continue to drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions."
• "We anticipate increased traction with consumers [for CareScout Services] as the CareScout Quality Network continues to expand and brand awareness grows."
• "We believe this product [Care Assurance] creates significant value for both our customers and distribution partners."
• "While it will take time to scale these businesses, we believe our investments in CareScout Services and CareScout Insurance will drive sustainable future growth for Genworth and are aligned with our overarching priority to maximize long-term value for our shareholders."
• "We will continue to strive to maintain a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders and opportunistically retiring debt."
• "Our long-term care insurance multi-year in-force rate action plan continues to be our most effective tool in supporting this strategic priority [maintaining self-sustaining legacy insurance subsidiaries]."
• "We continue to work closely with state regulators on our in-force long-term care insurance rate action plan (including increased premiums and associated benefit reductions) to achieve a shared goal of ensuring that our legacy insurance subsidiaries can honor their policyholder commitments in the future."
• "Returning capital to shareholders, balanced with growth and risk management priorities, remains a key commitment for Enact Holdings as it looks to enhance shareholder value through time."
• "Management has asserted that it has the ability and intent to execute tax planning strategies including holding certain investment assets with unrealized losses to recovery or maturity or realizing gains on certain investment assets with unrealized gains to the extent necessary to ensure realization of the capital related deferred tax assets."

Industry Context

StockSavvy.ai notes that Genworth Financial's strategic pivot towards aging care services and new long-term care insurance products through CareScout aligns with broader demographic trends of an aging population and increasing demand for elder care solutions. The continued strong performance and capital returns from its mortgage insurance segment (Enact) provide a stable foundation, a common strategy among diversified insurers to fund growth in emerging or re-focused areas. The competitive landscape in private mortgage insurance remains intense, with Enact maintaining its market position through risk-adjusted pricing and underwriting. The challenges in the Closed Block segment, particularly long-term care insurance, reflect industry-wide issues with legacy blocks, necessitating ongoing rate actions and assumption adjustments.

Comparison to Industry Standards

• Enact's PMIERs sufficiency ratio of 162% ($1,919 million above requirements) indicates a strong capital position relative to GSE mandates, comparable to leading private mortgage insurers in the U.S. market.
• The consolidated RBC ratio of Genworth's legacy insurance subsidiaries at approximately 300% is above the minimum regulatory thresholds, but the ongoing need for in-force rate actions in long-term care insurance highlights persistent challenges common across the long-term care insurance industry, where many older blocks of business face reserve adequacy issues.
• The increase in Enact's primary delinquency rate to 2.62% in 2025 from 2.45% in 2024, while a negative trend, should be assessed against overall housing market conditions and unemployment rates, which can impact all mortgage insurers. Its weighted-average FICO score of 746 for primary insurance in-force suggests a focus on prime borrowers, a common strategy for maintaining credit quality in a competitive market.

Management Changes

Corporate Governance

Legal Proceedings

• TVPX ARS, INC. v. GLAIC: A putative class action lawsuit alleging unlawful and excessive cost of insurance charges on life insurance policies. Genworth intends to vigorously defend this action, with a trial date scheduled for late April 2026.
• Burkhart et al. v. Genworth Financial et al.: A putative class action lawsuit alleging intentional and constructive fraudulent transfer by GLIC and inadequate capital maintenance. Genworth intends to vigorously defend this action.
• Trauernicht et al v. Genworth Financial: A putative class action lawsuit alleging breach of fiduciary duties under ERISA by imprudently offering and inadequately monitoring BlackRock Target Date Funds in the Savings Plan. The case is stayed pending an appeal to the Fourth Circuit, with oral argument occurring on October 21, 2025.
• M/O Arbitration Between Blue Cross Blue Shield Nebraska and GLIC: Arbitration related to BCBSNE's intent to recapture a block of long-term care insurance policies. The arbitration panel issued its final decision on May 19, 2025, resulting in a $24 million payment to BCBSNE and a $26 million pre-tax gain for Genworth.
• In Re MOVEit Customer Data Security Breach Litigation: Multiple putative class action lawsuits related to the MOVEit Cybersecurity Incident, alleging negligence, breach of contract, and violations of consumer protection laws. Most causes of action against Genworth were dismissed on July 31, 2025, but claims for common law negligence, breach of implied contract, and a Massachusetts statutory violation remain. Genworth intends to vigorously defend these actions.
• Fox v. GLAIC: A putative class action lawsuit alleging wrongful termination of California life insurance policies due to failure to provide mandated notices and grace periods. Genworth intends to vigorously defend this action.
• Kaplan v. GLIC: A putative class action lawsuit alleging misrepresentation and failure to disclose information regarding pricing structure and likelihood of rate increases for long-term care insurance policies. Genworth intends to vigorously defend this action.
• AXA S.A. (AXA) and Santander Cards UK Limited (Santander) litigation: High Court issued a liability judgment in favor of AXA on July 25, 2025, awarding approximately £680 million ($911 million). Santander applied for and was granted permission to appeal, and AXA sought and was granted permission to cross-appeal. The appeal hearing is scheduled for July 21-23, 2026. Genworth is entitled to share in recoveries, with $20 million received in November 2025 for an undisputed portion.

Related Party Transactions

• Genworth Holdings entered into an agreement with Enact Holdings to participate in Enact's share repurchase programs to maintain its ownership interest.
• Genworth Holdings received $407 million of capital returns from Enact Holdings in 2025, comprised of $309 million from share repurchases and $98 million from quarterly dividends.
• Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings' outstanding senior and subordinated notes.
• Genworth Financial provides an unconditional guarantee to a counterparty for an interest rate swap entered into by Genworth Holdings.
• Genworth Financial provides guarantees to third parties for the performance of certain lease obligations of its subsidiaries, estimated at approximately $47 million as of December 31, 2025.
• Genworth Holdings provided a limited guarantee of up to $175 million to one of its insurance subsidiaries to support its mortgage insurance business in Mexico, with exposure estimated at $135 million as of December 31, 2025.
• Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by its European mortgage insurance subsidiary prior to its sale in May 2016, with risk in-force of active policies approximately $800 million as of December 31, 2025.

Stakeholder Impact

• Shareholders: Impacted by decreased net income and adjusted operating income, but also by ongoing share repurchase programs and capital returns from Enact, indicating a commitment to shareholder value. Litigation outcomes could introduce volatility.
• Policyholders (Long-Term Care): Affected by ongoing premium rate increases and benefit reductions, which are critical for the sustainability of legacy policies. The new Care Assurance product aims to offer stable, customizable coverage.
• Policyholders (Life & Annuity): Impacted by block runoff and assumption updates, but also by efforts to manage these legacy products for long-term sustainability. Cybersecurity incidents pose a risk to personal data.
• Employees: Affected by the company's human capital management strategies, including compensation, benefits, professional development, and workplace inclusion initiatives. The flexible hybrid work approach is a key benefit.
• Customers (Enact): Benefit from Enact's strong capital position and competitive mortgage insurance products, which facilitate access to homeownership.
• Care Providers (CareScout): Expansion of the CareScout Quality Network creates opportunities for home care and senior living providers.
• Regulators: Ongoing engagement with state and federal regulators regarding long-term care rate actions, cybersecurity, and AI use, reflecting the highly regulated nature of the insurance industry.
• Creditors: Genworth Holdings' debt obligations and liquidity position are key, with no maturities until 2034 and a new revolving credit facility for Enact enhancing financial flexibility.

Next Steps

• Continue to expand the range of services and number of customers for CareScout Services in 2026.
• Launch worksite and association group offerings for CareScout Insurance later in 2026.
• Complete credentialing of Seniorly's major national senior living providers by the end of 2026.
• Continue to pursue significant premium rate increases and associated benefit reductions for long-term care insurance products in the Closed Block segment.
• Restructure one reinsurance contract to comply with the NAIC's December 2025 amendment by December 31, 2026.
• Enact Holdings expects to return approximately $500 million of capital to its shareholders in 2026.
• Genworth Financial expects to deploy any loss recoveries from the AXA litigation in line with capital allocation priorities: investing in CareScout, share repurchases, and opportunistic debt reduction.
• The appeal hearing for the AXA litigation against Santander is scheduled for July 21-23, 2026.
• A trial date has been scheduled for late April 2026 in the TVPX ARS, INC. v. GLAIC lawsuit.
• The company intends to continue to vigorously defend against ongoing class action lawsuits and regulatory matters.

Key Dates

Recommendation

Genworth Financial presents a mixed financial picture. While the core mortgage insurance business (Enact) continues to generate strong capital returns and maintain robust capital levels, the legacy Closed Block segment, particularly long-term care insurance, remains a drag on earnings due to unfavorable assumption updates and ongoing management challenges. The strategic pivot to CareScout offers long-term growth potential but is in its early stages and requires significant investment. The decline in net income and adjusted operating income in 2025, coupled with numerous ongoing legal proceedings, introduces uncertainty. The company's commitment to shareholder returns through repurchases is positive, but the overall financial performance and the inherent risks in its legacy businesses suggest a 'hold' recommendation. Investors should monitor the execution of the CareScout strategy, the progress of long-term care rate actions, and the outcomes of significant litigation.

Keywords

Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities, SEC Filing, Financial Services, Insurance, CareScout, Enact Holdings, Closed Block, Share Repurchase, Capital Returns, Risk Management, Cybersecurity, Artificial Intelligence, Regulatory Compliance, Financial Performance, Investment Portfolio, PMIERs, Actuarial Assumptions, Delinquencies, Seniorly Acquisition